鼻咽癌调强放疗后随访中常规磁共振成像的成本-效果分析
该研究用两个Markov模型比较了无影像临床随访与年度、半年一次磁共振成像随访在T1-2和T3-4期鼻咽癌调强放疗后完全缓解且无症状患者中的成本与效果。T1-2期患者中磁共振随访仅增加0.022-0.035个质量调整生命年(QALY),增量成本效果比(ICER)为328,389-403,857美元/QALY;T3-4期患者中年度和半年磁共振分别增加0.052和0.088个QALY,ICER为156,204和169,772美元/QALY。作者结论为T1-2期常规磁共振监测不具成本效果,而T3-4期年度磁共振监测为优势策略且可能具成本效果,取决于社会支付意愿。
要点
- T1-2期鼻咽癌放疗后常规磁共振随访仅增加0.022-0.035个QALY,ICER为328,389-403,857美元/QALY。
- T3-4期患者年度和半年磁共振分别增加0.052和0.088个QALY,ICER为156,204和169,772美元/QALY。
- 作者认为T1-2期常规磁共振监测不具成本效果,T3-4期年度磁共振为优势策略且可能具成本效果,取决于社会支付意愿。
核心结论
- T1-2期鼻咽癌调强放疗后常规磁共振监测因磁共振费用高且失败率低而不具成本效果。
- T3-4期患者年度磁共振监测为优势策略,且可能具成本效果,取决于社会支付意愿。
研究设计与样本
- 开发两个Markov模型,比较无连续影像的常规临床监测与治疗后前5年年度、半年一次磁共振监测三种策略的成本与效果。
- 分析两个假设队列:根治性治疗后达完全缓解且保持无症状的原发T1-2期或T3-4期鼻咽癌患者。
- 基线概率、转移概率、效用值和成本来自已发表研究,计算终生成本、质量调整生命年(QALY)和增量成本效果比(ICER)。
- 通过单因素和概率敏感性分析评估模型稳健性。
主要发现
- T1-2期患者中,年度磁共振较无磁共振临床随访增加0.022个QALY,半年磁共振增加0.035个QALY,而磁共振监测相关成本可观。
- T1-2期患者中,年度和半年磁共振策略较临床随访的ICER分别为328,389和403,857美元/QALY。
- T3-4期患者中,年度和半年磁共振监测分别增加0.052和0.088个QALY,ICER分别为156,204和169,772美元/QALY。
- 模型结论稳健,在单因素和概率敏感性分析中保持稳定。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To estimate the clinical benefit and cost-effectiveness of routine head and neck magnetic resonance imaging (MRI) in the follow-up of patients with nasopharyngeal carcinoma after definitive intensity modulated radiation therapy. PATIENTS AND METHODS: Two Markov models were developed to compare the cost and effectiveness of 3 strategies: routine clinical surveillance without serial imaging and routine annual and biannual MRI surveillance in the first 5 years. Two hypothetical cohorts of patients with primary stage T1-2 or T3-4 nasopharyngeal carcinoma who achieved complete remission after radical treatment and remained asymptomatic were analyzed. Baseline probabilities, transition probabilities, utilities, and costs were derived from published studies. Markov models were used to calculate life-time costs, quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios (ICERs). Model robustness was addressed via univariable and probabilistic sensitivity analyses. RESULTS: In T1-2 patients, surveillance strategies utilizing routine MRI provided few QALYs compared with non-MRI clinical follow-up (annual MRI, 0.022 QALYs; biannual MRI, 0.035 QALYs), whereas the costs associated with MRI surveillance were considerable. Compared with clinical follow-up, the ICERs for annual and biannual MRI strategies were $328,389 and $403,857 per QALY. In T3-4 patients, annual and biannual MRI surveillance provided 0.052 and 0.088 incremental QALYs, with ICERs of $156,204 and $169,772 per QALY, respectively. Model conclusions were robust and remained stable in 1-way and probabilistic sensitivity analyses. CONCLUSIONS: Routine MRI surveillance was not cost-effective owing to the high cost of MRI coupled with low rates of failure in T1-2 patients, whereas annual MRI surveillance was the dominant and possibly a cost-effective strategy for T3-4 patients, depending on the social willingness to pay.
引用
- Zhou GQ, Wu CF, Zhang J, et al. Cost-Effectiveness Analysis of Routine Magnetic Resonance Imaging in the Follow-Up of Patients With Nasopharyngeal Carcinoma After Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018. PMID: 29804816. doi:10.1016/j.ijrobp.2018.01.117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。